Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. The European Commission closes Tele2 investigation
Mandate

The European Commission closes Tele2 investigation

November 13, 2018 EU, Competition and Regulatory

On 25 April 2017 the European Commission conducted dawnraids at the premises of Tele2 and three other mobile network operators active in Sweden regarding potential infringements of EU competition law.

The Commission has informed Tele2 that the investigation has been closed without any further action. Vinge assisted Tele2 during the investigation.

Vinge’s team consisted of, among others, partners Johan Karlsson and Marcus Glader, economic expert Jakob Jeanrond and associates Johan Wahlbom and Xandra Ståhlberg.
 

Related

Vinge advises Aspo on its acquisition of Swed Handling

 Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

 Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

 Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024